Orodispersible minitablets of enalapril for use in children with heart failure (LENA): Rationale and protocol for a multicentre pharmacokinetic bridging study and follow-up safety study.

Contemporary Clinical Trials Communications(2019)

Cited 21|Views30
No score
Abstract
EudraCT 2015-002335-17, EudraCT 2015-002396-18, EudraCT 2015-002397-21.
More
Translated text
Key words
Clinical pharmacology,Paediatric cardiology,Heart failure,Dilated cardiomyopathy,Congenital heart disease
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined